VOLITIONRX LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and Business Update 2020-08-10 19:30
Volition Announces Promising Clinical Trials Results for its Novel COVID-19 Triage Test 2020-07-14 18:00
VolitionRx Releases Business Update Video and Announces Addition to the Russell 3000® and Russell Microcap® Indexes 2020-06-25 20:45
Volition Announces Cameron Reynolds, President and Chief Executive Officer Invited as Presenter at Maxim's COVID-19 Virtual Conference 2020-05-27 20:45
VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock 2020-05-23 04:01
VolitionRx Announces Pricing of Underwritten Public Offering of Common Stock 2020-05-20 20:45
VolitionRx Announces Proposed Underwritten Public Offering of Common Stock 2020-05-20 04:01
VolitionRx To Present First Data on Nu.Q™ Capture Performance and Nu.Q™ Assay Performance in Lung Cancer and Blood Cancer at the 2020 ASCO Annual Meeting 2020-05-14 06:54
VolitionRx Limited Announces First Quarter 2020 Financial Results and Business Update 2020-05-08 04:10
VolitionRx Limited Schedules First Quarter 2020 Earnings Conference Call and Business Update 2020-05-05 20:30
Volition's Nu.Q™ Vet Assay Detects Two Common Canine Cancers 2020-04-29 20:30
Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies 2020-04-23 20:30
VolitionRx Limited Releases Annual Corporate Brochure and Video 2020-03-10 20:45
VolitionRx Limited to Present at Conferences in March 2020 2020-03-03 21:30
VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update 2020-02-21 05:10
VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update 2020-02-19 05:10
Volition Unveils Its Epigenetic Toolbox 2020-02-18 21:30
VolitionRx Announces Filing of Registration Statements 2020-02-08 06:30
Volition Develops a New Improved Nu.Q™ Assay Format 2020-01-13 22:00
VolitionRx Completes Acquisition of Octamer GmbH 2020-01-10 21:00
1 2 3 4 5 11